Evidence map›Paper›PMID 42254842›Full record

ArticleFrontiers in ophthalmology2026

Case Report: Neuro-ophthalmic manifestations of petroclival meningioma.

Natalie Lanners, Ritu Sampige, Safa Ibrahim, Dina Abdelsalam, Andrew G Lee

Abstract readCase Reports
In one paragraph

Article in Frontiers in ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Natalie LannersMcGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, United States.
Ritu SampigeSchool of Medicine, Baylor College of Medicine, Houston, TX, United States.
Safa IbrahimDepartment of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, United States.
Dina AbdelsalamDepartment of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, United States.
Andrew G LeeDepartment of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To describe the neuro-ophthalmic manifestations of petroclival meningioma including multiple cranial neuropathies (e.g., trigeminal (V), abducens (VI), facial (VII), vestibulocochlear (VIII), glossopharyngeal (IX), vagus (X), accessory (XI), and hypoglossal (XII) dysfunction). Background: Petroclival meningiomas (PCM) are uncommon, benign skull base tumors that often present gradually but can lead to significant morbidity and mortality due to brainstem and lower cranial nerve involvement. Case presentation: A 42-year-old woman presented with gradual and progressive neck pain, headaches, and dysphagia. Neuroimaging showed a large petroclival meningioma with secondary obstructive hydrocephalus. She underwent staged surgical resections with near-gross total tumor resection. The patient subsequently developed new cranial nerve VI and VIII deficits. We also include a patient perspective of her condition as a unique aspect of the evaluation of PCM. Conclusion: PCM can present with multiple progressive cranial neuropathies due to tumor effects or as a consequence of surgical or radiation therapy. We believe that including a patient perspective in clinical reports might improve physician empathy and understanding of the patient's condition and course beyond the traditional evaluation and management paradigms for brain tumors including PCM.

Indexed as

abducens nerve palsycranial nerve palsiesdysphagiaiatrogenic complicationpetroclival meningioma

Identifiers

PMID42254842
PMCPMC13233223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.